ArticleOpen access2026
Risk factors for irinotecan-induced hepatotoxicity: a retrospective cohort study
Frontiers in Oncology · vol. 16 · 1777922-1777922
irinotecanhepatotoxicityrisk factorscumulative dose
Summary
The verified research profile for Mohammed Al‐Yamani comprises 11 scientific outputs indexed in Scopus.
Output by year
2020–2026Frontiers in Oncology · vol. 16 · 1777922-1777922
Vaccines · vol. 11 (3) · 518-518
Cureus · vol. 15 (4) · e37011-e37011
PeerJ · vol. 10 · e12732-e12732
Healthcare · vol. 10 (8) · 1520-1520